Sigma Planning Corp Lowers Position in Metlife Inc (MET)
Sigma Planning Corp decreased its position in Metlife Inc (NYSE:MET) by 17.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 17,924 shares of the financial services provider’s stock after selling 3,802 shares during the period. Sigma Planning Corp’s holdings in Metlife were worth $906,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in MET. Advisory Services Network LLC boosted its holdings in shares of Metlife by 19.8% in the second quarter. Advisory Services Network LLC now owns 9,665 shares of the financial services provider’s stock valued at $531,000 after purchasing an additional 1,596 shares during the period. Griffin Asset Management Inc. purchased a new stake in shares of Metlife in the second quarter valued at approximately $2,424,000. Intl Fcstone Inc. purchased a new stake in shares of Metlife in the second quarter valued at approximately $383,000. PGGM Investments boosted its holdings in shares of Metlife by 2.3% in the third quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock valued at $29,972,000 after purchasing an additional 12,978 shares during the period. Finally, Lincoln Capital Corp boosted its holdings in shares of Metlife by 9.6% in the third quarter. Lincoln Capital Corp now owns 75,946 shares of the financial services provider’s stock valued at $3,945,000 after purchasing an additional 6,664 shares during the period. Hedge funds and other institutional investors own 76.55% of the company’s stock.
MET has been the subject of a number of recent research reports. ValuEngine downgraded shares of Metlife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 9th. Zacks Investment Research raised shares of Metlife from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research note on Thursday, November 9th. Wells Fargo & Co set a $62.00 price objective on shares of Metlife and gave the stock a “buy” rating in a research note on Thursday, December 14th. Argus boosted their price objective on shares of Metlife from $55.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, November 6th. Finally, Goldman Sachs Group reissued a “buy” rating on shares of Metlife in a research note on Wednesday, January 31st. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $57.77.
Metlife (NYSE:MET) last issued its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.41). Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. During the same period last year, the company earned $1.28 EPS. equities research analysts anticipate that Metlife Inc will post 4.42 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Monday, February 5th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.56%. The ex-dividend date of this dividend is Friday, February 2nd. Metlife’s payout ratio is presently 36.87%.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.